Athos Bousvaros

Publications

1. HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease. Am J Gastroenterol. 2024 Oct 18. View Abstract
2. Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease. Inflamm Bowel Dis. 2024 Oct 17. View Abstract
3. Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 Oct 16. View Abstract
4. Cytomegalovirus Colitis in a Patient With Ulcerative Colitis With Loss of Corticosteroid Response Upon Upadacitinib Initiation. Gastroenterol Hepatol (N Y). 2024 Oct; 20(9):546-549. View Abstract
5. Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 Sep 03; 30(9):1443-1453. View Abstract
6. Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease. Sci Rep. 2024 08 06; 14(1):18188. View Abstract
7. High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease. Am J Gastroenterol. 2024 06 01; 119(6):1110-1116. View Abstract
8. Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024 Jul; 22(7):1475-1486.e4. View Abstract
9. Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):871-877. View Abstract
10. Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Feb; 78(2):261-271. View Abstract
11. Collaborative Registries for Pediatric Crohn's Disease: A Leap Forward or More of the Same? Am J Gastroenterol. 2024 03 01; 119(3):450-451. View Abstract
12. Comparing Gastrointestinal Endoscopy Findings in Children with Autism, Developmental Delay, or Typical Development. J Pediatr. 2024 Jan; 264:113737. View Abstract
13. Endoscopy of the Ileal Pouch Anal Anastomosis. J Pediatr Gastroenterol Nutr. 2023 12 01; 77(6):691-694. View Abstract
14. Reply. Gastroenterology. 2023 Nov; 165(5):1308. View Abstract
15. Helicobacter pylori Antimicrobial Resistance Using Next-Generation Sequencing in Stool Samples in a Pediatric Population. J Pediatr Gastroenterol Nutr. 2023 11 01; 77(5):623-627. View Abstract
16. Treatment of Genital Crohn's Disease With Upadacitinib in a Male Child: A Case Report. Gastroenterol Hepatol (N Y). 2023 Jul; 19(7):401-403. View Abstract
17. Efficacy and Safety of Tacrolimus or Infliximab Therapy in Children and Young Adults With Acute Severe Colitis. J Pediatr Gastroenterol Nutr. 2023 08 01; 77(2):222-227. View Abstract
18. Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial. Gastroenterology. 2023 07; 165(1):149-161.e7. View Abstract
19. Helicobacter pylori Antimicrobial Resistance in a Pediatric Population From the New England Region of the United States. Clin Gastroenterol Hepatol. 2023 12; 21(13):3458-3460.e2. View Abstract
20. Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 03 01; 29(3):483-486. View Abstract
21. How to Write an Effective Letter of Medical Necessity. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):407-409. View Abstract
22. Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease. medRxiv. 2023 Feb 01. View Abstract
23. Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):460-467. View Abstract
24. Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis. Gastroenterology. 2023 04; 164(4):610-618.e4. View Abstract
25. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflamm Bowel Dis. 2022 10 03; 28(10):1497-1505. View Abstract
26. Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. Am J Gastroenterol. 2023 01 01; 118(1):129-137. View Abstract
27. Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease. J Crohns Colitis. 2022 Sep 08; 16(9):1380-1396. View Abstract
28. Denials, Dilly-dallying, and Despair: Navigating the Insurance Labyrinth to Obtain Medically Necessary Medications for Pediatric Inflammatory Bowel Disease Patients. J Pediatr Gastroenterol Nutr. 2022 10 01; 75(4):418-422. View Abstract
29. Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022 03 01; 117(3):462-469. View Abstract
30. Lessons From a Quality Improvement Project to Standardize the Process of Gastric Biopsy Culture for Helicobacter pylori. JPGN Rep. 2021 Nov; 2(4):e116. View Abstract
31. Agreement on Symptoms Between Children With Ulcerative Colitis and Their Caregivers: Towards Developing the TUMMY-UC. J Pediatr Gastroenterol Nutr. 2021 08 01; 73(2):e35-e38. View Abstract
32. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. Gastroenterology. 2020 08; 159(2):591-608.e10. View Abstract
33. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis. 2020 05 12; 26(6):820-842. View Abstract
34. The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease. Gastroenterol Rep (Oxf). 2020 Oct; 8(5):404-406. View Abstract
35. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. Inflamm Bowel Dis. 2019 11 14; 25(12):1927-1938. View Abstract
36. Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease. PLoS One. 2019; 14(10):e0222952. View Abstract
37. The pharmacotherapeutic management of pediatric Crohn's disease. Expert Opin Pharmacother. 2019 Dec; 20(17):2161-2168. View Abstract
38. Natural history of children with mild Crohn's disease. World J Gastroenterol. 2019 08 14; 25(30):4235-4245. View Abstract
39. Commentary: Monitoring Thiopurine Efficacy Without Levels: Is It a Good Idea? J Pediatr Gastroenterol Nutr. 2019 07; 69(1):1-2. View Abstract
40. Microscopic/"Backwash" Ileitis and Its Association With Colonic Disease in New Onset Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2019 06; 68(6):835-840. View Abstract
41. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S40-S47. View Abstract
42. Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary. Gut. 2020 01; 69(1):32-41. View Abstract
43. Microscopic / "Backwash" Ileitis and its Association with Colonic Disease in New Onset Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2019 Jan 21. View Abstract
44. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. Inflamm Bowel Dis. 2019 01 01; 25(1):27-32. View Abstract
45. Reducing Redundant Anaerobic Therapy Through Spaced Education and Antimicrobial Stewardship Interventions. J Pediatric Infect Dis Soc. 2018 Dec 03; 7(4):317-322. View Abstract
46. Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. Inflamm Bowel Dis. 2018 11 29; 24(12):2565-2578. View Abstract
47. Curved planar reformatting and convolutional neural network-based segmentation of the small bowel for visualization and quantitative assessment of pediatric Crohn's disease from MRI. J Magn Reson Imaging. 2019 06; 49(6):1565-1576. View Abstract
48. The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 05 18; 24(6):1344-1351. View Abstract
49. Educational needs in the diagnosis and management of pediatric functional constipation: a US survey of specialist and primary care clinicians. Postgrad Med. 2018 May; 130(4):428-435. View Abstract
50. Commentary: Button Batteries in Fidget Spinners: Is It Time to Push the "Panic Button"? J Pediatr Gastroenterol Nutr. 2018 04; 66(4):557-558. View Abstract
51. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children. Clin Gastroenterol Hepatol. 2018 09; 16(9):1467-1473. View Abstract
52. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial. Gut. 2019 02; 68(2):239-247. View Abstract
53. Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab. J Pediatr Surg. 2018 Jul; 53(7):1330-1333. View Abstract
54. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflamm Bowel Dis. 2017 11; 23(11):1950-1961. View Abstract
55. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J Exp Med. 2017 Jul 03; 214(7):1937-1947. View Abstract
56. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. World J Gastroenterol. 2017 May 14; 23(18):3322-3329. View Abstract
57. Outcomes From Pediatric Gastroenterology Maintenance of Certification Using Web-based Modules. J Pediatr Gastroenterol Nutr. 2017 05; 64(5):671-678. View Abstract
58. From "Jarts" to "Zen Magnets": Protecting Our Children from Dangerous Toys. J Pediatr. 2017 07; 186:6-7. View Abstract
59. O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. Inflamm Bowel Dis. 2017 Feb; 23 Suppl 1:S4. View Abstract
60. Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression. J Pediatr Gastroenterol Nutr. 2016 12; 63(6):658-664. View Abstract
61. Interleukin 1ß Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology. 2016 12; 151(6):1100-1104. View Abstract
62. Postoperative Complications in Children With Crohn Disease Treated With Infliximab. J Pediatr Gastroenterol Nutr. 2016 09; 63(3):352-6. View Abstract
63. Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents. J Pediatr. 2016 Nov; 178:227-232. View Abstract
64. NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-a Inhibitors. J Pediatr Gastroenterol Nutr. 2016 07; 63(1):130-55. View Abstract
65. O-017 YI Inflammatory Versus Non-inflammatory Predictors of Specific Depressive Symptoms in a Large Pediatric Cohort with IBD. Inflamm Bowel Dis. 2016 Mar; 22 Suppl 1:S6. View Abstract
66. Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders. Inflamm Bowel Dis. 2015 Oct; 21(10):2281-8. View Abstract
67. Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. Inflamm Bowel Dis. 2015 Aug; 21(8):1750-1. View Abstract
68. Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. Inflamm Bowel Dis. 2015 Jun; 21(6):1321-8. View Abstract
69. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. J Pediatr. 2015 Sep; 167(3):527-32.e1-3. View Abstract
70. Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease. Clin Gastroenterol Hepatol. 2015 Oct; 13(10):1748-56. View Abstract
71. Surgical management and morbidity of pediatric magnet ingestions. J Surg Res. 2015 Nov; 199(1):137-40. View Abstract
72. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015 Feb; 39(2):245-50. View Abstract
73. Functional significance of single nucleotide polymorphisms in the lactase gene in diverse US patients and evidence for a novel lactase persistence allele at -13909 in those of European ancestry. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):182-91. View Abstract
74. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. Inflamm Bowel Dis. 2015 Feb; 21(2):307-14. View Abstract
75. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study. Gut. 2015 Dec; 64(12):1898-904. View Abstract
76. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Aug; 20(8):1329-40. View Abstract
77. Benefit/risk assessment of biologic monotherapy vs combination therapy in Crohn's Remains Challenging. Gastroenterology. 2014 Aug; 147(2):540. View Abstract
78. Pediatric ulcerative colitis: a practical guide to management. Paediatr Drugs. 2014 Jun; 16(3):189-98. View Abstract
79. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease. Inflamm Bowel Dis. 2014 Jun; 20(6):1015-20. View Abstract
80. Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. Gastroenterol Hepatol (N Y). 2014 Jun; 10(6):355-63. View Abstract
81. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014 Jul; 53(7):726-35. View Abstract
82. Authors' response. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):e51. View Abstract
83. Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):569-73. View Abstract
84. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):574-81. View Abstract
85. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014 Apr 09; 14:71. View Abstract
86. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):309-18. View Abstract
87. Advocating for child health: how the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition took action against high-powered magnets. J Pediatr. 2014 Jan; 164(1):4-5.e1. View Abstract
88. NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):130-8. View Abstract
89. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):e44-100. View Abstract
90. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):343-7. View Abstract
91. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):293-7. View Abstract
92. Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):335-42. View Abstract
93. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. J Pediatr Surg. 2013 Jul; 48(7):1540-5. View Abstract
94. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One. 2013; 8(6):e63686. View Abstract
95. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jun; 19(7):1441-9. View Abstract
96. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):826-31. View Abstract
97. Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum. Expert Rev Clin Immunol. 2013 Feb; 9(2):117-27. View Abstract
98. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013 Jan; 56(1):12-8. View Abstract
99. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013 Jan; 19(1):96-109. View Abstract
100. Management of ingested magnets in children. J Pediatr Gastroenterol Nutr. 2012 Sep; 55(3):239-42. View Abstract
101. Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. J Clin Psychol Med Settings. 2012 Sep; 19(3):329-37. View Abstract
102. Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn's disease. J Magn Reson Imaging. 2013 Jan; 37(1):156-63. View Abstract
103. Budesonide use in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2012 Aug; 55(2):200-4. View Abstract
104. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012 Sep; 107(9):1399-406. View Abstract
105. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012; 7(6):e39242. View Abstract
106. An i2b2-based, generalizable, open source, self-scaling chronic disease registry. J Am Med Inform Assoc. 2013 Jan 01; 20(1):172-9. View Abstract
107. Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor. Compr Psychiatry. 2012 Nov; 53(8):1194-9. View Abstract
108. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr 16; 13(9):R79. View Abstract
109. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2012 May; 18(5):935-42. View Abstract
110. Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. Inflamm Bowel Dis. 2012 May; 18(5):838-43. View Abstract
111. "Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis. J Clin Gastroenterol. 2011 Jul; 45(6):479-80. View Abstract
112. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr. 2011 Jun; 52(6):708-13. View Abstract
113. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011 Apr; 106(4):574-88. View Abstract
114. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol. 2011 May; 106(5):981-7. View Abstract
115. Innate and adaptive immune connections in inflammatory bowel diseases. Curr Opin Gastroenterol. 2010 Nov; 26(6):572-7. View Abstract
116. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflamm Bowel Dis. 2011 Jan; 17(1):22-9. View Abstract
117. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):140-5. View Abstract
118. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Expert Rev Clin Immunol. 2010 Jul; 6(4):659-66. View Abstract
119. Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol. 2010 Sep; 8(9):789-94. View Abstract
120. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J Pediatr Gastroenterol Nutr. 2010 May; 50(5):562-5. View Abstract
121. Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol. 2010 Jun; 105(6):1430-6. View Abstract
122. Probiotic for new onset ulcerative colitis in children: baby's got bac(teria). Inflamm Bowel Dis. 2010 Jan; 16(1):177-8. View Abstract
123. Monitoring Disease Activity in Pediatric IBD Patients (monograph). Children's Digestive Health and Nutrition Foundation 2009 . 2010. View Abstract
124. Healthcare burden of inflammatory bowel disease in the United States: more than pain and diarrhea. Inflamm Bowel Dis. 2009 Nov; 15(11):1767-8. View Abstract
125. Restorative proctocolectomy and ileal pouch-anal anastomosis in children. Dis Colon Rectum. 2009 Sep; 52(9):1645-9. View Abstract
126. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009 Sep; 15(9):1417-23. View Abstract
127. Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2009 Sep; 49(3):297-303. View Abstract
128. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009 Aug; 15(8):1218-23. View Abstract
129. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis. 2009 Jun; 15(6):816-22. View Abstract
130. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis. 2009 Mar; 15(3):383-7. View Abstract
131. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr. 2009 Feb; 48(2):168-74. View Abstract
132. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009 Feb; 104(2):444-53. View Abstract
133. Making the right diagnosis: differentiating between Crohn disease and ulcerative colitis in children and young adults. . 2009. View Abstract
134. Approach to clinical diagnosis of inflammatory bowel disease. In: Walker-Smith JA, Lebenthal E, Branski D. Pediatric Inflammatory Bowel Disease: Perspective and consequences. 2009; 123-137. View Abstract
135. Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res. 2008 Aug; 52(8):867-74. View Abstract
136. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis. 2008 Jul; 14(7):949-54. View Abstract
137. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008 Apr; 20(4):269-84. View Abstract
138. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis. 2008 Jan; 40(1):32-8. View Abstract
139. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007 Oct; 46(10):1290-1298. View Abstract
140. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec; 5(12):1424-9. View Abstract
141. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007 Nov; 151(5):523-7. View Abstract
142. Challenges and progress in pediatric inflammatory bowel disease. Curr Opin Gastroenterol. 2007 Jul; 23(4):406-12. View Abstract
143. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007 Jul; 13(7):890-5. View Abstract
144. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. 2007 Jun; 119(6):1113-9. View Abstract
145. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007 May; 44(5):653-74. View Abstract
146. Pete Learns About Crohn's and Colitis. 2007. View Abstract
147. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007 Jan; 42(1):31-4; discussion 34-5. View Abstract
148. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006 Dec; 12(12):1101-6. View Abstract
149. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Sep; 12(9):885-913. View Abstract
150. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Aug; 12(8):684-91. View Abstract
151. Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers. Inflamm Bowel Dis. 2006 Aug; 12(8):814-23. View Abstract
152. Medical therapy for refractory pediatric Crohn's disease. Clin Gastroenterol Hepatol. 2006 Oct; 4(10):1199-213. View Abstract
153. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1124-9. View Abstract
154. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1118-23. View Abstract
155. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis. 2006 Apr; 12(4):251-7. View Abstract
156. Gastrointestinal issues in developmentally disabled children. LI Rubin and AC Crocker eds. Medical Care for children and adults with developmental disabilities. 2006; 307-324. View Abstract
157. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006; 8(5):279-302. View Abstract
158. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005 Oct; 41(4):416-21. View Abstract
159. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005 Sep; 11(9):833-9. View Abstract
160. Workshop report: prevention of postoperative recurrence in Crohn's disease. J Pediatr Gastroenterol Nutr. 2005 Aug; 41(2):145-51. View Abstract
161. Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis. 2005 Jun; 11(6):519-27. View Abstract
162. Normal homocysteine levels in a population of children with inflammatory bowel disease. Inflamm Bowel Dis. 2005 Jun; 11(6):620-1. View Abstract
163. A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis. 2005 Feb; 11(2):185-96. View Abstract
164. Probiotic Therapies: the crossroads of traditional and alternative medicine. Practical Gastroenterology. 2005; 4:20-36. View Abstract
165. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004 Nov; 99(11):2235-41. View Abstract
166. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2004 Oct; 39(4):395-403. View Abstract
167. Mucosal healing in children with Crohn's disease: appropriate therapeutic goal or medical overkill? Inflamm Bowel Dis. 2004 Jul; 10(4):481-3. View Abstract
168. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004 Feb; 28(2):190-7. View Abstract
169. Gastroenterology questions for the American Academy of Pediatrics PREP course. Available on www.pedialink.org. 2004. View Abstract
170. Immunosuppressive therapies. Walker WA, Goulet O, Kleinman R, Sherman P, Shneider B, Sanderson I eds. Pediatric Gastrointestinal Disease. 2004; 2:2015-2044. View Abstract
171. Pediatric Crohn's disease. Johnson L ed. Encyclopedia of Gastroenterology. 2004; 520-527. View Abstract
172. Ulcerative colitis. Guandalini ed, Textbook of Pediatric Gastroenterology. 2004; 385-418. View Abstract
173. Gastroenterologic and Liver Disorders. Stiehm ER, Ochs H, Winkelstein J eds. Immunologic disorders in infants and children. 2004; 1055-1102. View Abstract
174. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol. 2003 Dec; 98(12):2712-8. View Abstract
175. Blocking lymphocyte adhesion: new treatment for sticky cases of Crohn disease? J Pediatr Gastroenterol Nutr. 2003 Aug; 37(2):211-3. View Abstract
176. Isolated neonatal swallowing dysfunction: a case series and review of the literature. Dig Dis Sci. 2003 Jan; 48(1):30-5. View Abstract
177. Nutritional therapy of inflammatory bowel disease. Caballero B, Trugo L, Finglas P eds. Encyclopedia of Food Sciences and Nutrition. 2003; 3315-3320. View Abstract
178. Webcast: Crohn's and colitis Foundation - Management of IBD in special populations. Available on www.ccfa.org. 2003. View Abstract
179. Feeding tubes. Puder M, Hansen A eds. Manual of Neonatal Surgical Care. 2003; 303-314. View Abstract
180. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002 Nov; 47(11):2625-34. View Abstract
181. Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2002 Nov; 35(5):695-9. View Abstract
182. Blame Canada: growing questions about budesonide. Inflamm Bowel Dis. 2002 May; 8(3):235. View Abstract
183. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol. 2002 Feb; 97(2):382-8. View Abstract
184. Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 3:S286-90. View Abstract
185. Board review questions in pediatric gastroenterology for the American Academy of Pediatrics PREP the course. 16 Questions per year for 6 years (2002-2008). 2002. View Abstract
186. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):548-53. View Abstract
187. Inflammatory bowel disease associated with immune thrombocytopenic purpura in children. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):582-7. View Abstract
188. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):602-5. View Abstract
189. Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. J Pediatr Gastroenterol Nutr. 2001 Aug; 33(2):149-54. View Abstract
190. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001 Jan; 120(1):13-20. View Abstract
191. Thalidomide in gastrointestinal disorders. Drugs. 2001; 61(6):777-87. View Abstract
192. Epidemiology and diagnosis of inflammatory bowel disease. Bonis ed., Up to Date. 2001; 9. View Abstract
193. The spectrum of pediatric gastroesophageal reflux. JAMA. 2000 Dec 27; 284(24):3125-6. View Abstract
194. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000 Dec; 137(6):794-9. View Abstract
195. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999 Dec; 44(12):2500-7. View Abstract
196. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol. 1999 Apr; 23(4):390-6. View Abstract
197. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci. 1999 Feb; 44(2):424-30. View Abstract
198. Gastrointestinal Manifestations of Primary Immunodeficiencies. Wyllie R, Hyams JS. Pediatric Gastrointestinal Disease. 1999; 381-389. View Abstract
199. Crohn's disease in children and adolescents. Bonis ed, Up to Date (CD-ROM). 1999; 8. View Abstract
200. Ulcerative Colitis in children and adolescents. Bonis ed, Up to Date (CD-ROM). 1999. View Abstract
201. Gastrointestinal issues in the child with developmental disabilities. International Seminars in Pediatric Gastroenterology and Nutrition. 1999; 8:1-9. View Abstract
202. Intraduodenal hematoma complicating intestinal biopsy: case reports and review of the literature. Am J Gastroenterol. 1998 Dec; 93(12):2547-50. View Abstract
203. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med. 1998 Nov; 152(11):1132-6. View Abstract
204. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol. 1998 Nov; 26(5):365-9. View Abstract
205. Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1998 May; 26(5):500-5. View Abstract
206. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998 Feb; 26(2):129-35. View Abstract
207. Clinical outcome of ulcerative proctitis in children. J Pediatr Gastroenterol Nutr. 1997 Aug; 25(2):149-52. View Abstract
208. Preventing relapse after surgery for Crohn's disease: where do we go from here? J Pediatr Gastroenterol Nutr. 1997 Jul; 25(1):114-5. View Abstract
209. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes. Dig Dis Sci. 1997 Jul; 42(7):1542-8. View Abstract
210. Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. Dig Dis Sci. 1997 Feb; 42(2):378-86. View Abstract
211. Gastroenterologic Disorders. Graef J, Priebe C eds. Manual of Pediatric Therapeutics. 1997. View Abstract
212. Immunosuppressive Agents in Gastrointestinal Disease. Kresina T, ed. Manual of Immune Modulating Agents. 1997. View Abstract
213. Tacrolimus (FK-506) treatment of fulminant colitis in a child. J Pediatr Gastroenterol Nutr. 1996 Oct; 23(3):329-33. View Abstract
214. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1996 Aug; 23(2):164-71. View Abstract
215. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology. 1996 Jul; 111(1):237-43. View Abstract
216. Immunology and Gastrointestinal Disease. Stiehm ER ed, Immunologic Disorders of Infants and Children. 1995; 697-741. View Abstract
217. Immunosuppressive Agents in Gastrointestinal Disease. Current Opinion in Gastroenterology. 1995; 11:554-561. View Abstract
218. Immunosuppressive therapies in Pediatric Gastroenterology. Walker WA, Hamilton JR, Watkins JB, Walker-Smith JA, Durie PR. Pediatric Gastrointestinal Disease. 1995. View Abstract
219. New immunotherapies and their potential for treatment of inflammatory bowel disease. Progress in Inflammatory Bowel Disease. 1993; 14:6-11. View Abstract
220. Immunology and Gastrointestinal Disease. Wyllie R and Hyams J eds., Pediatric Gastrointestinal Disease. 1993; 64-73. View Abstract
221. Basic gastrointestinal immunology. Bouchier IA, Hodgson HJ, Keighley MR eds., Gastroenterology: Clinical Science and Practice. 1993; 577-582. View Abstract
222. Ringed esophagus: an association with esophagitis. Am J Gastroenterol. 1992 Sep; 87(9):1187-90. View Abstract
223. Development of the Intestinal Mucosal Barrier. McDonald TT ed, Ontogeny of the Immune System of the Gut. 1991. View Abstract
224. Diarrhea in the Immunodeficient Host. Rudolph's Textbook of Pediatrics. 1991; 1012-1015. View Abstract
225. Abdominal Wall Defects. Rudolph Textbook of Pediatrics. 1991; 1040-1042. View Abstract
226. Imaging of neuroblastoma: an overview. Pediatr Radiol. 1986; 16(2):89-106. View Abstract
227. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. Am J Pathol. 1985 Dec; 121(3):514-21. View Abstract
Show All Publications Show Fewer Publications